This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Neuro-ophthalmology, 3rd ed.
edited by Joel S. Glaser,
667 pp., Philadelphia, Lippincott Williams & Wilkins, 1999, $115.00
Since the appearance of the first edition in 1977, this work has served as the first-line, go-to text in neuro-ophthalmology for trainees and practitioners. For the beginner, there are essential chapters on history and examination. (The visage of the editor appears in some sections demonstrating the examination, too.) A separate chapter is devoted to special techniques employed in the neuro-ophthalmic examination. Instructions for conducting a funduscopic examination are omitted, however, probably because this text is also published as part of a six-volume looseleaf reference for ophthalmologists (Clinical Ophthalmology, William Tasman and Edward Jaeger, eds). Thorough discussions follow on the visual and oculomotor systems. Chapters are also devoted to the pupil, orbit, pediatric disorders, headache, vascular disorders, and the vestibular system. Functional visual loss is one common clinical problem that receives only limited attention.
The effort to retain the high quality of previous editions is achieved. From four contributors in the first edition to 14 in the second, there are now 20 distinguished authors. Ten ophthalmologists and eight neurologists provide important perspectives from the two disciplines and a resource of practical information for clinical use. One chapter, on the dizzy patient, has been added since the last edition. Over one third of the references are new. Illustrations and tables are instructive and numerous. Nonetheless, the length has been contained so that the text extends only to 667 pages.
Neuro-ophthalmology is concisely written, authoritative, and generally comprehensive. General neurologists will find the book very useful for the diagnosis of a broad range of neuro-ophthalmologic disorders. Recommendations for management usually follow general guidelines. Suggestions for more definitive treatment are often terse, so the neurologist may need to seek alternative sources if additional …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen